Quest Diagnostics Incorporated company logo

# RNN 2nd Gen Model Quest Diagnostics Incorporated Medical laboratories

Prediction models:
59.62% successful of 52 deals
$ 97.23 Last close price
at 17-may-2019


Model's trade recommendations -0.34% Return for period

-1.56% Annual return

$13.77B Market Cap

β 0.71  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period -0.34%
52wk return 7.71%
52wk Range
Sortino ratio -0.22
Sharpe ratio -0.18
Norm. RMSE 1.97%
Downside risk 7.02%
Volatility 0.00%
  • 2.00 (1.97%) Div (Yield)
  • BUY Analysts consensus recommendation

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.

Industry sector: Medical

Sector classification: Medical laboratories

Deep Learning based analysis and prediction model for Quest Diagnostics Incorporated (DGX) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for DGX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a regular basis.

Float 133M
P/E 17.36
Shares Outstanding 136M
% Held by Insiders 1.79%
% Held by Institutions 88.84%
EPS (last reported FY) $5.40
EPS (last reported Q) $1.52
EPS, estimated (last reported Q) $1.52
Total revenues $8 B
Net income $1 B